Bulevirtide vs Melanotan II

Overview

Bulevirtide is primarily a antiviral peptide, while Melanotan II is used for cosmetic & skin.

This page compares Bulevirtide and Melanotan II across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.

Side-by-side comparison

Key differences

Primary use. Bulevirtide is categorised under Antiviral, while Melanotan II falls under Cosmetic & Skin. Their differing categories mean they are usually chosen for different goals rather than as direct substitutes.

Regulatory status. Bulevirtide: FDA-approved. Melanotan II: not FDA-approved; compounding permitted with a prescription as of April 2026.

Dosing. Typical dosing for Bulevirtide is not catalogued. Melanotan II is typically dosed at 250-500 mcg (as needed).

Can you stack them?

Some protocols combine peptides, but stacking Bulevirtide and Melanotan II has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.

Frequently asked questions

What is the difference between Bulevirtide and Melanotan II?

Bulevirtide is primarily a antiviral peptide, while Melanotan II is used for cosmetic & skin. Bulevirtide is FDA-approved for one or more indications, whereas Melanotan II is not FDA-approved; compounding permitted with a prescription (as of April 2026).

What is Bulevirtide used for?

First/only FDA-approved treatment for chronic hepatitis delta virus (HDV). FDA accelerated approval May 22, 2026. Brand: Hepcludex (Gilead).

What is Melanotan II used for?

Tanning, libido.

Can you take Bulevirtide and Melanotan II together?

Some users combine peptides within a single protocol, but stacking Bulevirtide and Melanotan II has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.

Is Bulevirtide or Melanotan II FDA-approved?

Bulevirtide is FDA-approved for one or more indications. Melanotan II is not FDA-approved; compounding permitted with a prescription (as of April 2026).